These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31671001)

  • 21. Misuse of methamphetamine and prescription stimulants among youths and young adults in the community.
    Wu LT; Pilowsky DJ; Schlenger WE; Galvin DM
    Drug Alcohol Depend; 2007 Jul; 89(2-3):195-205. PubMed ID: 17257780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescription psychostimulants as a harm reduction and treatment intervention for methamphetamine use disorder and the implications for nursing clinical practice: A scoping review of the literature.
    Leidl D; Takhar P; Li H
    Int J Ment Health Nurs; 2023 Oct; 32(5):1225-1242. PubMed ID: 36978242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy for methamphetamine/amphetamine use disorder-a systematic review and meta-analysis.
    Chan B; Freeman M; Kondo K; Ayers C; Montgomery J; Paynter R; Kansagara D
    Addiction; 2019 Dec; 114(12):2122-2136. PubMed ID: 31328345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions.
    Rose ME; Grant JE
    Ann Clin Psychiatry; 2008; 20(3):145-55. PubMed ID: 18633741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The stigmatisation of 'ice' and under-reporting of meth/amphetamine use in general population surveys: A case study from Australia.
    Chalmers J; Lancaster K; Hughes C
    Int J Drug Policy; 2016 Oct; 36():15-24. PubMed ID: 27450550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin attenuates depressive-like behaviour of methamphetamine withdrawal in mice: A mechanistic approach.
    Hosseini MJ; Arabiyan A; Mobassem S; Ghavimi H
    World J Biol Psychiatry; 2023 Mar; 24(3):209-222. PubMed ID: 35673936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anxiety level and correlates in methamphetamine-dependent patients during acute withdrawal.
    Su H; Zhang J; Ren W; Xie Y; Tao J; Zhang X; He J
    Medicine (Baltimore); 2017 Apr; 96(15):e6434. PubMed ID: 28403074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic Regulatory Dynamics in Models of Methamphetamine-Use Disorder.
    Jayanthi S; McCoy MT; Cadet JL
    Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccine development against methamphetamine drug addiction.
    Hossain MK; Hassanzadeganroudsari M; Nurgali K; Apostolopoulos V
    Expert Rev Vaccines; 2020 Dec; 19(12):1105-1114. PubMed ID: 33251859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychiatric symptoms and HPA axis function in adolescent methamphetamine users.
    King G; Alicata D; Cloak C; Chang L
    J Neuroimmune Pharmacol; 2010 Dec; 5(4):582-91. PubMed ID: 20358305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot randomised controlled trial of modafinil during acute methamphetamine withdrawal: feasibility, tolerability and clinical outcomes.
    Lee N; Pennay A; Hester R; McKetin R; Nielsen S; Ferris J
    Drug Alcohol Rev; 2013 Jan; 32(1):88-95. PubMed ID: 22630616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Effect of Buprenorphine on Methamphetamine Cravings.
    Salehi M; Emadossadat A; Kheirabadi GR; Maracy MR; Sharbafchi MR
    J Clin Psychopharmacol; 2015 Dec; 35(6):724-7. PubMed ID: 26468683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The epidemiology of methamphetamine use and harm in Australia.
    Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
    Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor 2 AZD8529 on Incubation of Methamphetamine Craving After Prolonged Voluntary Abstinence in a Rat Model.
    Caprioli D; Venniro M; Zeric T; Li X; Adhikary S; Madangopal R; Marchant NJ; Lucantonio F; Schoenbaum G; Bossert JM; Shaham Y
    Biol Psychiatry; 2015 Oct; 78(7):463-73. PubMed ID: 25861699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxytocin-enhanced motivational interviewing group therapy for methamphetamine use disorder in men who have sex with men: study protocol for a randomized controlled trial.
    Stauffer CS; Moschetto JM; McKernan SM; Hsiang E; Borsari B; Woolley JD
    Trials; 2019 Feb; 20(1):145. PubMed ID: 30791944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methamphetamine abstinence induces changes in μ-opioid receptor, oxytocin and CRF systems: Association with an anxiogenic phenotype.
    Georgiou P; Zanos P; Garcia-Carmona JA; Hourani S; Kitchen I; Laorden ML; Bailey A
    Neuropharmacology; 2016 Jun; 105():520-532. PubMed ID: 26896754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. l-Scoulerine attenuates behavioural changes induced by methamphetamine in zebrafish and mice.
    Mi G; Gao Y; Yan H; Jin X; Ye E; Liu S; Gong Z; Yang H; Yang Z
    Behav Brain Res; 2016 Feb; 298(Pt A):97-104. PubMed ID: 26433144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial.
    Ahmadi J; Razeghian Jahromi L
    Trials; 2017 Jun; 18(1):259. PubMed ID: 28587620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive Deficits in Methamphetamine Users: How Strong is The Evidence?
    Proebstl L; Kamp F; Koller G; Soyka M
    Pharmacopsychiatry; 2018 Nov; 51(6):243-250. PubMed ID: 29334687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methods in drug abuse models: comparison of different models of methamphetamine paradigms.
    Kobeissy FH; Mitzelfelt JD; Fishman I; Morgan D; Gaskins R; Zhang Z; Gold MS; Wang KK
    Methods Mol Biol; 2012; 829():269-78. PubMed ID: 22231820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.